Please login to the form below

Not currently logged in
Email:
Password:

UCB CEO elected to the Ministerial Industry Strategy Group

Jean-Christophe Tellier assumed the role of CEO on January 1
Jean-Christophe Tellier

UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG).

Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies.

Commenting on the election, Tellier said: “The UK life sciences industry is one of the most successful at a global level and it is an important contributor to the country's economic prosperity.

“Therefore, I am pleased to be sharing some of UCB's experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of Novartis pharma France. He has 25 years of experience in the industry, aided by a medical background as a rheumatologist.

Tellier was named as UCB's next CEO early last year, but did not assume the role until January 1 of this year.

25th February 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics